# The Use of Magtrace®/Sentimag® in Sentinel Node Biopsy for Malignant Melanoma. The Magmen Study.

> **NCT03898687** · NA · COMPLETED · sponsor: **Sahlgrenska University Hospital** · enrollment: 15 (actual)

## Conditions studied

- Melanoma
- Sentinel Lymph Node

## Interventions

- **DEVICE:** SLN Biopsy with Magtrace®/Sentimag®

## Key facts

- **NCT ID:** NCT03898687
- **Lead sponsor:** Sahlgrenska University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03898687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03898687, "The Use of Magtrace®/Sentimag® in Sentinel Node Biopsy for Malignant Melanoma. The Magmen Study.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03898687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*